Latest Articles
Leveraging the Role of Microbiome in Endometriosis: Novel Non-Invasive Diagnostic and Therapeutic Approaches - Frontiers
Leveraging the Role of Microbiome in Endometriosis: Novel Non-Invasive Diagnostic and Therapeutic Approaches Frontiers
Published: Aug. 26, 2025, 3:55 p.m.
Can Bladder Endometriosis Be Hard to Diagnose? A two-case report and literature review - Frontiers
Can Bladder Endometriosis Be Hard to Diagnose? A two-case report and literature review Frontiers
Published: Aug. 26, 2025, 3:33 p.m.
Olaparib Maintenance in Advanced Endometrial Cancer Trial - BIOENGINEER.ORG
Olaparib Maintenance in Advanced Endometrial Cancer Trial BIOENGINEER.ORG
Published: Aug. 26, 2025, 3:07 p.m.
I Tested Every Lelo Sex Toy—and My Favorite Ones Are Up to 40% Off for Labor Day - Prevention
I Tested Every Lelo Sex Toy—and My Favorite Ones Are Up to 40% Off for Labor Day Prevention
Published: Aug. 26, 2025, 3:01 p.m.
Rina-S Wins FDA Breakthrough Therapy Designation for Advanced or Recurrent Endometrial Cancer - OncLive
Rina-S Wins FDA Breakthrough Therapy Designation for Advanced or Recurrent Endometrial Cancer OncLive
Published: Aug. 26, 2025, 3:01 p.m.
Genmab's Rina-S: A Breakthrough in Gynecologic Oncology and a Catalyst for Value Creation - AInvest
Genmab's Rina-S: A Breakthrough in Gynecologic Oncology and a Catalyst for Value Creation AInvest
Published: Aug. 26, 2025, 1:01 p.m.
Why Jemperli and Zejula will be key assets in GSK's India oncology portfolio? - MSN
Why Jemperli and Zejula will be key assets in GSK's India oncology portfolio? MSN
Published: Aug. 26, 2025, 12:50 p.m.
Stanhope Street group serves up support for women facing period poverty - Not Really Here Group
Stanhope Street group serves up support for women facing period poverty Not Really Here Group
Published: Aug. 26, 2025, 12:37 p.m.
Strictly Come Dancing's Anton Du Beke's wild three-word reaction to wife - MSN
Strictly Come Dancing's Anton Du Beke's wild three-word reaction to wife MSN
Published: Aug. 26, 2025, 12:35 p.m.
Why Jemperli and Zejula will be key assets in GSK’s India oncology portfolio? - Business Today
Why Jemperli and Zejula will be key assets in GSK’s India oncology portfolio? Business Today
Published: Aug. 26, 2025, 12:29 p.m.
Link copied to clipboard!